Blood bank

The Worldwide Market for In Vitro Diagnostic Tests, 16th Edition - COVID-19 Impact, Regions of Market Influence and What to Watch For Long-Term - ResearchAndMarkets.com

Retrieved on: 
Wednesday, December 27, 2023

The "Worldwide Market for In Vitro Diagnostic Tests, 16th Edition" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Worldwide Market for In Vitro Diagnostic Tests, 16th Edition" report has been added to ResearchAndMarkets.com's offering.
  • The 16th edition of The Worldwide Market for In Vitro Diagnostic Tests is based on vendor reporting, interviews, vendor activities, and more on a global scale.
  • The 16th edition of the Worldwide Market for In Vitro Diagnostic Tests is a must have for anyone interested or involved in the IVD industry.
  • The 16th edition of the Worldwide Market for In Vitro Diagnostic Tests provides readers with reliable estimates, real-world forecasts, and insights needed to understand the IVD market in its entirety.

Boekel Scientific Introduces New Centrifuge Product Line

Retrieved on: 
Monday, August 21, 2023

FEASTERVILLE-TREVOSE, Pa., Aug. 21, 2023 /PRNewswire/ -- Boekel Scientific introduces a new product line that consists of 4 families of centrifuges : economy, general purpose, STAT, and Blood Bank .

Key Points: 
  • FEASTERVILLE-TREVOSE, Pa., Aug. 21, 2023 /PRNewswire/ -- Boekel Scientific introduces a new product line that consists of 4 families of centrifuges : economy, general purpose, STAT, and Blood Bank .
  • Boekel Scientific, renowned for its storied history within the labware and laboratory apparatus manufacturing field, is well versed in centrifugation.
  • This new line of centrifuges combine modern technologies such as LED light indicators and brushless motors with the trusted Boekel Scientific quality and durability known for generations.
  • The Boekel Scientific centrifuges are all proudly made in the USA, with design, manufacturing, and product support residing in Pennsylvania.

Responding to Need for Blood, a San Diego Blood Drive will be Held on Monday, March 20th from 9:00am to 2:30pm at Better Business Bureau, 4747 Viewridge Ave., San Diego

Retrieved on: 
Tuesday, March 7, 2023

SAN DIEGO, March 7, 2023 /PRNewswire-PRWeb/ -- The life-saving work of the San Diego Blood Bank serves hospitals in Southern California, including trauma centers and neonatal intensive care units. A single donation can help save up to three lives. As Southern California continues to grow, the need to expand blood collections is essential. Every donation saves lives.

Key Points: 
  • SAN DIEGO, March 7, 2023 /PRNewswire-PRWeb/ -- The life-saving work of the San Diego Blood Bank serves hospitals in Southern California, including trauma centers and neonatal intensive care units.
  • "We are proud to collaborate with the San Diego Blood Bank in encouraging people to donate."
  • "We are grateful for the opportunity to positively impact our community by partnering with the San Diego Blood Bank to support this donation drive."
  • We're proud to support the life-saving donation drive and partner with fantastic organizations like the San Diego Blood Bank," says Christine Daniels, vice president of marketing, Mulligan Funding .

PDC*line Pharma Presents First Immunological Results From Phase I/II Trial With PDC*lung01 at ESMO-IO 2022

Retrieved on: 
Friday, December 9, 2022

The preliminary data was presented today at a poster display session at the ESMO Immuno-Oncology Congress 2022 (ESMO-IO) in Geneva (Switzerland).

Key Points: 
  • The preliminary data was presented today at a poster display session at the ESMO Immuno-Oncology Congress 2022 (ESMO-IO) in Geneva (Switzerland).
  • The objectives of the phase I/II trial (PDC-LUNG-101) are to assess the safety, tolerability, immunogenicity and preliminary clinical activity of the drug candidate PDC*lung01, associated or not with anti-PD-1 treatment in NSCLC patients.
  • It is administered weekly by a subcutaneous and intravenous route, in six consecutive doses.
  • Safety and clinical activity of the product were presented at ESMO 2022 in September 2022 in Paris (France).

Doctors at Manipal Hospitals, Delhi successfully treats 6-year-old Iraqi girl for rare brain disease

Retrieved on: 
Wednesday, November 30, 2022

NEW DELHI, Nov. 30, 2022 /PRNewswire/ --In a rare incidence, doctors at Manipal Hospitals, Delhi, successfully performed a special cerebral revascularization surgery on a 6-year-old girl from Iraq.

Key Points: 
  • NEW DELHI, Nov. 30, 2022 /PRNewswire/ --In a rare incidence, doctors at Manipal Hospitals, Delhi, successfully performed a special cerebral revascularization surgery on a 6-year-old girl from Iraq.
  • But, with the support from the Iraqi Ministry of Health, the family brought the little girl to India.
  • She was initially referred because of suspicion of a vascular malformation in her brain, but on further investigation, it was revealed that she was suffering from a rare condition called MoyaMoya Disease.
  • MoyaMoya Disease is a rare disease where the arteries supplying blood to the brain start to shrink.

Doctors at Manipal Hospitals, Delhi successfully treats 6-year-old Iraqi girl for rare brain disease

Retrieved on: 
Wednesday, November 30, 2022

NEW DELHI, Nov. 30, 2022 /PRNewswire/ --In a rare incidence, doctors at Manipal Hospitals, Delhi, successfully performed a special cerebral revascularization surgery on a 6-year-old girl from Iraq.

Key Points: 
  • NEW DELHI, Nov. 30, 2022 /PRNewswire/ --In a rare incidence, doctors at Manipal Hospitals, Delhi, successfully performed a special cerebral revascularization surgery on a 6-year-old girl from Iraq.
  • But, with the support from the Iraqi Ministry of Health, the family brought the little girl to India.
  • She was initially referred because of suspicion of a vascular malformation in her brain, but on further investigation, it was revealed that she was suffering from a rare condition called MoyaMoya Disease.
  • MoyaMoya Disease is a rare disease where the arteries supplying blood to the brain start to shrink.

Worldwide In Vitro Diagnostic Tests Market Report 2022 with Profiles of 200+ Companies - Financial Results, Product Launches, Company History and Strategic Plans - ResearchAndMarkets.com

Retrieved on: 
Tuesday, November 22, 2022

The 15th edition of The Worldwide Market for In Vitro Diagnostic Tests provides readers with reliable estimates, real-world forecasts, and insights needed to understand the IVD market in its entirety.

Key Points: 
  • The 15th edition of The Worldwide Market for In Vitro Diagnostic Tests provides readers with reliable estimates, real-world forecasts, and insights needed to understand the IVD market in its entirety.
  • The full assessment of the IVD diagnostic market makes The Worldwide Market for In Vitro Diagnostic Tests the most trusted report by top companies in the industry.
  • The in vitro diagnostics market is a global one, and The Worldwide Market for In Vitro Diagnostic (IVD) Tests reflects the international scope of the in vitro diagnostics market size.
  • The report concentrates over a thousand pages on detailed and tiered profiles of companies in the in vitro diagnostics market.

PDC*line Pharma Presents First Clinical Results From Phase I/II trial With PDC*lung01 at ESMO 2022

Retrieved on: 
Tuesday, September 13, 2022

The preliminary data was presented today at a poster discussion session at the 2022 European Society for Medical Oncology (ESMO) Annual Meeting.

Key Points: 
  • The preliminary data was presented today at a poster discussion session at the 2022 European Society for Medical Oncology (ESMO) Annual Meeting.
  • The objectives of the phase I/II trial (PDC-LUNG-101) are to assess the safety, tolerability, immunogenicity and preliminary clinical activity of the drug candidate PDC*lung01, associated with, or not, anti-PD-1 treatment in NSCLC patients.
  • Results are reported on the first three cohorts that have been completed (A1/A2/B1).
  • With preliminary clinical data now available from patients of the first three enrolled cohorts, it is encouraging to see PDC*lung01 as safe, immunogenic and to have signs of clinical efficacy.

TerraPro Solutions, Better Business Bureau (BBB) Serving the Pacific Southwest, and Mulligan Funding, Team Up with San Diego Blood Bank for Life-Saving Donation Drive

Retrieved on: 
Wednesday, August 17, 2022

SAN DIEGO, Aug. 17, 2022 /PRNewswire-PRWeb/ -- The life-saving work of the San Diego Blood Bank serves hospitals in Southern California, including trauma centers and neonatal intensive care units. A single donation can help save up to three lives. As Southern California continues to grow, the need to expand blood collections in the region is critical. Every donation saves lives.

Key Points: 
  • The San Diego Blood Drive will be held on Friday, September 9th, from 10:00am to 4:00pm at the Better Business Bureau, 4747 Viewridge Ave., San Diego, CA 92123.
  • SAN DIEGO, Aug. 17, 2022 /PRNewswire-PRWeb/ -- The life-saving work of the San Diego Blood Bank serves hospitals in Southern California, including trauma centers and neonatal intensive care units.
  • "We are extremely grateful that TerraPro Solutions, BBB Pacific Southwest's San Diego Campus and Mulligan Funding have joined forces to host a life-saving blood drive."
  • San Diego Blood Bank is a 501(c)(3) nonprofit organization also operating as Southern California Blood Bank.

Sysmex America Receives FDA Clearance for Residual White Blood Cell Counting

Retrieved on: 
Wednesday, June 15, 2022

LINCOLNSHIRE, Ill., June 15, 2022 /PRNewswire/ -- Sysmex America, Inc., a leading diagnostic solutions company offering hematology, urinalysis, information systems and flow cytometry testing technology for optimal clinical laboratory performance, has received FDA clearance for the addition of residual white blood cell counting to its XN-10 Automated Hematology Analyzer with Blood Bank mode. This is the first and only automated hematology analyzer to be FDA-cleared for residual WBC counting. The latest analyzer supports red blood cell (RBC) and platelet (PLT) component testing along with residual white blood cell counting in a single sample aspiration, providing blood processing centers with increased efficiency, consistency and accuracy. 

Key Points: 
  • LINCOLNSHIRE, Ill., June 15, 2022 /PRNewswire/ -- Sysmex America, Inc. , a leading diagnostic solutions company offering hematology, urinalysis, information systems and flow cytometry testing technology for optimal clinical laboratory performance, has received FDA clearance for the addition of residual white blood cell counting to its XN-10 Automated Hematology Analyzer with Blood Bank mode.
  • The latest analyzer supports red blood cell (RBC) and platelet (PLT) component testing along with residual white blood cell counting in a single sample aspiration, providing blood processing centers with increased efficiency, consistency and accuracy.
  • Sysmex America's XN-10 with Blood Bank mode is a holistic solution that offers accurate cell counts on products that are key to blood centers and blood banks.
  • "Sysmex America's XN-10 Automated Hematology Analyzer with Blood Bank mode is a holistic solution that covers donors, patients and blood components," said Andy Hay, chief executive officer of Sysmex America.